Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia
NCT00253123 is registered in ClinicalTrials.gov with Janssen, LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia
- Lead sponsor
- Janssen, LP
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- March 31, 1997
- Enrollment
- 626 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.